IP Library Granted Patent US 8,680,080
Granted Patent B2
US 8,680,080 · App. 13/280,182 · Granted Mar 25, 2014

Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,680,080
App. No.
13/280,182
Granted
Mar 25, 2014
Kind
B2
Abstract

A phospholipid extract from a marine or aquatic biomass possesses therapeutic properties. The phospholipid extract comprises a variety of phospholipids, fatty acid, metals and a novel flavonoid.

Claims (33)

1. A method of treating Alzheimer's disease comprising administering to a patient in need thereof an effective amount of a phospholipid composition, wherein the phospholipid composition comprises:

a phospholipid of the general formula (I),

wherein R1 and R2, each together with the respective carboxyl groups to which each is attached, each independently represents a docosahexaenoic acid (DHA) or an eicosapentaenoic acid (EPA) residue, and

wherein X is —CH 2 CH 2 NH 3 , —CH 2 CH 2 N(CH 3 ) 3 or

wherein the composition is suitable for human consumption.

2. The method of claim 1 , wherein X is

3. A method of treating Alzheimer's disease comprising administering to a patient in need thereof an effective amount of a krill oil extract,

wherein:

the extract comprises a phospholipid of the formula (I),

wherein:

R1 and R2, each together with the respective carboxyl groups to which each is attached, each independently represents a docosahexaenoic acid (DHA) or an eicosapentaenoic acid (EPA) residue, and X is —CH 2 CH 2 NH 3 , —CH 2 CH 2 N(CH 3 ) 3 , or

the extract is extracted under conditions suitable for preserving an intact phospholipid;

the extract comprises phospholipids in an amount of at least 40% w/w;

the extract comprises omega-3 fatty acids in an amount of at least 15% w/w;

the extract comprises astaxanthin; and

the extract is suitable for human consumption.

4. The method of claim 3 , wherein said composition is contained in a tablet or capsule suitable for oral administration.

5. A method of treating Alzheimer's disease comprising administering to a patient in need thereof an effective amount of a phospholipid composition, wherein the phospholipid composition comprises:

a phospholipid of the general formula (I),

wherein R1 and R2, each together with the respective carboxyl groups to which each is attached, each independently represents a docosahexaenoic acid (DHA) or an eicosapentaenoic acid (EPA) residue, and

wherein X is

wherein the composition is suitable for human consumption.

6. A method of treating Alzheimer's disease comprising administering to a patient in need thereof an effective amount of a krill oil extract,

wherein:

the krill oil extract comprises a phospholipid of the formula (I),

wherein:

R1 and R2, each together with the respective carboxyl groups to which each is attached, each independently represents a docosahexaenoic acid (DHA) or an eicosapentaenoic acid (EPA) residue, and X is

the extract is extracted under conditions suitable for preserving an intact phospholipid;

the extract comprises phospholipids in an amount of at least 40% w/w;

the extract comprises omega-3 fatty acids in an amount of at least 15% w/w;

the extract comprises astaxanthin; and

the extract is suitable for human consumption.

7. The method of claim 6 , wherein said composition is contained in a tablet or capsule suitable for oral administration.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: NEPTUNE TECHNOLOGIES & BIORESSOURCES, INC.
To: AKER BIOMARINE ANTARCTIC AS
Reel/Frame 043525/0925 →
RELEASE OF SECURITY INTEREST Recorded Aug 24, 2017
From: BANK AND CLIENTS PLC
To: NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
Reel/Frame 043389/0273 →
MORTGAGE Recorded Apr 19, 2016
From: NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.
To: BANK AND CLIENTS PLC
Reel/Frame 038463/0304 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2012
From: SAMPALIS, FONTINI
To: NEPTUNE TECHNOLOGIES & BIORESSOURCES, INC.
Reel/Frame 027573/0496 →